Blood Brain Barrier (BBB) Disruption for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 14 Sep 2018: Trial registered, NCT03671889
  2. 14 Nov 2018: Trial registered, NCT03739905

The trials

NCT03671889: ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

State
Under way
Phase
No phase
People
50 planned
Started
28 Sep 2018
Primary completion
Jan 2028
Arms
Blood Brain Barrier (BBB) Disruption
Results
None posted
  1. 14 Sep 2018: Trial registered
  2. 28 Sep 2018: Trial started

NCT03739905: ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease

State
Completed
Phase
No phase
People
35 taking part
Started
6 Dec 2018
Primary completion
9 Apr 2025
Arms
Blood Brain Barrier (BBB) Disruption
Results
None posted
  1. 14 Nov 2018: Trial registered
  2. 6 Dec 2018: Trial started
  3. 9 Apr 2025: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.